The highly invasive ESCC sublines that were established in this study not only confirms the significance of the PI3K/AKT pathway in ESCC metastasis, but will be valuable tools for evaluating novel therapeutic agents which can curb tumor metastasis. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.